QA: Altimmune Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001326190_2023_Altimmune_Inc.pdf

Logs

Graph

Absolute values for 0001326190, Altimmune Inc.

  xvar xval
0 AssetsCurrent 192,813,000
1 IntangibleAssetsNetIncludingGoodwill 12,419,000
2 PropertyPlantAndEquipmentNet 1,081,000
3 remainder_Assets 615,000
4 LiabilitiesCurrent 17,054,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 4,581,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 17,134,000
9 ResearchAndDevelopmentExpense 70,538,000
10 remainder_Expenses -197,000
11 remainder_Revenues -68,000
12 remainder_NetIncome 2,830,000
13 remainder_ComprehensiveNetIncome -187,000
  yvar yval
0 Assets 206,928,000
1 Liabilities 21,635,000
2 Expenses 87,475,000
3 Revenues -68,000
4 StockholdersEquity 185,293,000
5 NetIncome -84,713,000
6 ComprehensiveNetIncome -84,806,500
7 BaseVar 159,561,500
8 EconomicCapitalRatio 2.05

Edgar->Model Mapping

Feature Distribution

Change over Time